A trial looking at the best time for surgery after
treatment for rectal cancer. Cancer Research UK.
Available at: http://www.cancerresearchuk.org/
cancer-help/trials/a triallooking-best-time-surgeryafter-
treatment-rectalcancer?=1#list.
Aschele, C., L. Cionini, S. Lonardi, et al. Primary
tumor response to preoperative chemoradiation
with or without oxaliplatin in locally advanced
rectal cancer: pathologic results of the STAR-01
randomized phase III trial.- J. Clin. Oncol., 29,
, No 20, 2773-2780.
Borschitz, T., D. Wachtlin, M. Mohler, et al.
Neoadjuvant chemoradiation and local excision for
T2-3 rectal cancer.- Ann. Surg. Oncol., 15, 2008, No
, 712-720.
Bosset, J. F., L. Collette, G. Calais, et al.
Chemotherapy with preoperative radiotherapy in
rectal cancer.- New Engl. J. Med., 355, 2006, No 11,
-1123.
Bujko, K., M. P. Nowacki, A. Nasierowska-
Guttmejer, et al. Long-term results of a randomized
trial comparing preoperative short-course
radiotherapy with preoperative conventionally
fractionated chemoradiation for rectal cancer.- Br.
J. Surg., 93, 2006, No 10, 1215-1223.
Callender, G. G., P. Das, M. Rodriguez-Bigas, et al.
Local excision after preoperative chemoradiation
results is an equivalent outcome to total mesorectal
excision in selected patients with T3 rectal cancer.-
Ann. Surg. Oncol., 17, 2010, No 2, 441-447.
Collette, L., J. F. Bosset, M. den Dulk, et al. Patients
with curative resection of cT3-4 rectal cancer after
preoperative radiotherapy or radiochemotherapy:
does anybody benefit from adjuvant fluorouracilbased
chemotherapy? A trial of the European
Organisation for Research and Treatment of
Cancer Radiation Oncology Group.- J. Clin. Oncol.,
, 2007, No 28, 4379-4386.
Colorectal Cancer Collaborative Group. Adjuvant
radiotherapy for rectal cancer: a systematic
overview of 8,507 patients from 22 randomised
trials.- Lancet, 358, 2001, No 9290, 1291-1304.
Dewdney, A., D. Cunningham, J. Tabernero, et
al. EXPERT-C: a randomized phase II European
multicenter trial of neoadjuvant chemotherapy
(capecitabine/oxaliplatin) and chemoradiation
(CRT) with or without cetuximab followed by total
mesorectal excision (TME) in patients with MRIdefined
high-risk rectal cancer.- J. Clin. Oncol., 29,
, Suppl. 4, abstract p. 360.
Dresen, R. C., M. J. Gosens, H. Martijn, et
al. Radical resection after IORT-containing
multimodality treatment is the most important
determinant for outcome in patients treated for
locally recurrent rectal cancer.- Ann. Surg. Oncol.,
, 2008, No 7, 1937-1947.
Dzik-Jurask, A., C. Domenig, M. George, et al.
Diffusion MRI for prediction of response of rectal
cancer to chemoradiation.- Lancet, 360, 2002, No
, 307-308.
Folkesson, J., H. Birgisson, L. Pahlman, et al.
Swedish Rectal Cancer Trial: long lasting benefits
from radiotherapy on survival and local recurrence
rate.- J. Clin. Oncol., 23, 2005, No 24, 5644-5650.
Garcia-Aguilar, J., Q. Shi, C. R. Thomas, et
al. Pathologic complete response (pCR) to
neoadjuvant chemoradiation (CRT) of uT2UN0
rectal cancer (RC) treated by local excision (LE).
Results of the ACOSOG Z6041 trial.- J. Clin.
Oncol., 28, 2010, Suppl. 15, abstract p. 3510.
Gavioli, M., A. Bagni, I. Piccagli, et al. Usefulness
of endorectal ultrasound after preoperative
radiotherapy in rectal cancer.- Dis. Colon Rectum,
, 2000, No 8, 1075-1083.
Gérard, J. P., T. Conroy, F. Bonnetain, et al.
Preoperative radiotherapy with or without
concurrent fluorouracil and leucovorin in T3-4
rectal cancers: results of FFCD 9203.- J. Clin.
Oncol., 24, 2006, No 28, 4620-4625.
Gérard, J. P., D. Azria, S. Gourgou-Bourgade,
et al. Comparison of two neoadjuvant
chemoradiotherapy regimens for locally advanced
rectal cancer: results of the phase III trial accord
/0405-Prodige 2.- J. Clin. Oncol., 28, 2010, No 10,
-1644.
Glynne-Jones, R., M. Wallace, J. L. Livingstone, et
al. Complete clinical response after preoperative
chemoradiation in rectal cancer: is a `wait and see`
policy justified?- Dis. Colon Rectum, 51, 2008, No
, 10-20.
Guiney, M. J., J. G. Smith, V. Worotniuk, et al.
Radiation therapy treatment for isolated locoregional
recurrence of rectosigmoid cancer
following definitive surgery: Peter MacCallum
Cancer Institute experience, 1981-1990.- Int.
J. Radiat. Oncol. Biol. Phys., 38, 1997, No 5,
-1025.
Habr-Gama, A., R. O. Perez, W. Nadalin, et al.
Operative versus nonoperative treatment for stage
distal rectal cancer following chemoradiation
therapy: long-term results.- Ann. Surg., 240, 2004,
No 4, 711-717.
Haddock, M. G., R. C. Miller, H. Nelson, et
al. Combined modality therapy including
intraoperative electron irradiation for locally
recurrent colorectal cancer.- Int. J. Radiat. Oncol.
Biol. Phys., 79, 2011, No 1, 143-150.
Hahnloser, D., M. G. Haddock, H. Nelson.
Intraoperative radiotherapy in the multimodality
approach to colorectal cancer.- Surg. Oncol. Clin. N.
Am., 12, 2003, No 4, 993-1013.
Hofheinz, R. D., F. Wenz, S. Post, et al.
Chemoradiotherapy with capecitabine versus
fluorouracil for locally advanced rectal cancer: a
randomised, multicentre, noninferiority, phase 3
trial.- Lancet Oncol., 13, 2012, No 6, 579-588.
Jacobsen, A. K. M., A. L. Appelt, J. Lindebjerg, et
al. The dose-effect relationship in preoperative
chemoradiation of locally advanced rectal cancer:
preliminary results of a phase III trial.- J. Clin.
Oncol., 29, 2011, abstract p. 3512.
Kapiteijn, E., C. A. M. Marijnen, I. D. Nagtegaal, et
al. Preoperative radiotherapy combined with total
mesorectal excision for resectable rectal cancer.-
New Engl. J. Med., 345, 2001, No 9, 638-646.
Knol, H. P., P. E. Hanssens, H. J. Rutten, et al.
Effect of radiation therapy alone or in combination
with surgery and/or chemotherapy on tumor
and symptom control of recurrent rectal cancer.-
Strahlenther. Onkol., 173, 1997, No 1, 43-49.
Kundel, Y., R. Brenner, O. Purim, et al. Is local
excision after complete pathological response to
neoadjuvant chemoradiation for rectal cancer an
acceptable treatment option?- Dis. Colon Rectum,
, 2010, No 12, 1624-1631.
Lybeert, M. L., H. Martijn, W. de Neve, et al.
Radiotherapy for locoregional relapses of rectal
carcinoma after initial radical surgery: definite
but limited influence on relapse-free survival and
survival.- Int. J. Radiat. Oncol. Biol. Phys., 24, 1992,
No 2, 241-246.
Ngan, S. Y., B. Burmeister, R. J. Fisher, et al.
Randomized trial of short-course radiotherapy
versus long-course chemoradiation comparing
rates of local recurrence in patients with T3
rectal cancer: Trans-Tasman Radiation Oncology
Group trial 01.04.- J. Clin. Oncol., 30, 2012, No 31,
-3833.
Nielsen, M. B., S. Laurberg, T. Holm. Current
management of locally recurrent rectal cancer.-
Colorectal Dis., 13, 2011, No 7, 732-742.
Pählman, L., B. Glimelius, et al. Improved survival
with preoperative radiotherapy in resectable rectal
cancer: Swedish Rectal Cancer Trial.- New Engl. J.
Med., 336, 1997, No 14, 980-987.
Peeters, K. C., C. A. Marijnen, I. D. Nagtegaal,
et al. The TME trial after a median follow-up of
years: increased local control but no survival
benefit in irradiated patients with resectable rectal
carcinoma.- Ann. Surg., 246, 2007, No 5, 693-701.
Pettersson, D., B. Cederniark, T. Holm, et al.
Interim analysis of the Stockholm III trial of
preoperative radiotherapy regimens for rectal
cancer.- Br. J. Surg., 97, 2010, No 4, 580-587.
Ratto, C., V. Valentini, A. G. Morganti, et al.
Combined-modality therapy in locally advanced
primary rectal cancer.- Dis. Colon Rectum, 46,
, No 1, 59-67.
Roedel, C. Preoperative chemoradiotherapy and
postoperative chemotherapy with 5-fluorouracil
and oxaliplatin versus 5-fluorouracil alone in
locally advanced rectal cancer: first results of the
German CAO/ARO/AIO-04 randomized phase
III trial.- J. Clin. Oncol., 29, 2011, Suppl., abstract
LBA3505.
Roeder, F., M. Treiber, S. Oertel, et al. Patterns
of failure and local control after intraoperative
electron boost radiotherapy to the presacral space
in combination with total mesorectal excision
in patients with locally advanced rectal cancer.-
Int. J. Radiat. Oncol. Biol. Phys., 67, 2007, No 5,
-1388.
Roeder, F., J. M. Goetz, G. Habl, et al.
Intraoperative electron radiation therapy (IOERT)
in the management of locally recurrent rectal
cancer.- BMC Cancer, 12, 2012 Dec, 592.
Roh, M. S., G. A. Yothers. The impact of
capecitabine and oxaliplatin in the preoperative
multimodality treatment in patients with
carcinoma of the rectum: NSABP R-04.- J. Clin.
Oncol., 29, 2011, abstract p. 3503.
Sauer, R., H. Becker, W. Hohenberger,
et al. Preoperative versus postoperative
chemoradiotherapy for rectal cancer.- New Engl. J.
Med., 351, 2004, No 17, 1731-1740.
Sebag-Montefiore, D., K. Bujko, V. Valentini. Rectal
cancer multidisciplinary management: evidences
and future landscape.- Radiother. Oncol., 92, 2009,
No 2, 145-147.
Sebag-Montefiore, D., R. J. Stephens, R. Steele,
et al. Preoperative radiotherapy versus selective
postoperative chemoradiotherapy in patients with
rectal cancer (MRC CR07 and NCIC-CTG C016): a
multicentre, randomised trial.- Lancet, 373, 2009,
No 9666, 811-820.
STA RRCAT Trial: Surgical timing after
radiotherapy for rectal cancer. Available at: http://
www.controlled-trials.com/ISRCTN88843062/.
Stephens, R. J., L. C. Thompson, P. Quirke, et al.
Impact of short-course preoperative radiotherapy
for rectal cancer on patient`s quality of life: data
from the Medical Research Council CR07/National
Cancer Institute of Canada Clinical Trials Group
C016 randomized clinical trial.- J. Clin. Oncol., 28,
, No 27, 4233-4239.
Sun Myint, A., T. Mukhopadhyay, V. S. Ramani,
et.al. Can increasing the dose of radiation by HDR
brachytherapy boost following pre-operative
chemoradiotherapy for advanced rectal cancer
improve surgical outcomes?- Colorectal Dis., 12,
, Suppl. 2, 30-36.
Valentini, V, R. Beets-Tan, J. M. Borras, et al.
Evidence and research in rectal cancer.- Radiother.
Oncol., 87, 2008, No 3, 449-474.
Van Gijn, W., C. A. Marijnen, I. D. Nagtegaal, et
al. Preoperative radiotherapy combined with total
mesorectal excision for resectable rectal cancer:
-year follow-up of the multicentre, randomised
controlled TME trial. Dutch Colorectal Cancer
Group.- Lancet Oncol., 12, 2011, No 6, 575-582.
Willett, C. G., D. Duda, E. di Tomaso, et al.
Efficacy, safety, and biomarkers of neoadjuvant
bevacizumab, radiation therapy, and fluorouracil
in rectal cancer: a multidisciplinary phase II study.-
J. Clin. Oncol., 27, 2009, No 18, 3020-3026.
Wong, C. S., B. J. Cummings, J. D. Brierley, et al.
Treatment of locally recurrent rectal carcinoma:
results and prognostic factors.- Int. J. Radiat. Oncol.
Biol. Phys., 40, 1998, No 2, 427-435.
Wong, R. K., Tandan V, De Silva S, et al. Preoperative
radiotherapy and curative surgery for
the management of localized rectal carcinoma.-
Cochrane Database Syst. Rev., 2007, No 2,
CD002102.
Email this article (Login required) 
